Stay updated on TransCon IL-2 β/γ Clinical Trial
Sign up to get notified when there's something new on the TransCon IL-2 β/γ Clinical Trial page.

Latest updates to the TransCon IL-2 β/γ Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe date has been updated from February 5, 2025, to March 13, 2025.SummaryDifference0.6%
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check44 days agoChange DetectedThe page now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with a new date of February 5, 2025, while the previous date of January 8, 2025, has been removed.SummaryDifference6%
- Check52 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check73 days agoChange DetectedThe website has added a new version (v2.14.0) of the 'type of intervention' feature on January 8, 2025, while the previous version (v2.13.3) was removed on October 15, 2024.SummaryDifference2%
Stay in the know with updates to TransCon IL-2 β/γ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TransCon IL-2 β/γ Clinical Trial page.